Olanzapine for schizophrenia
Olanzapine for schizophrenia is a topic covered in the Evidence-Based Medicine Guidelines.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this entry is available only to subscribers.
Citation
"Olanzapine for Schizophrenia." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/455091/all/__________Olanzapine_for_schizophrenia______.
Olanzapine for schizophrenia. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/455091/all/__________Olanzapine_for_schizophrenia______. Accessed April 18, 2021.
Olanzapine for schizophrenia. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/455091/all/__________Olanzapine_for_schizophrenia______
Olanzapine for Schizophrenia [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2021 April 18]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/455091/all/__________Olanzapine_for_schizophrenia______.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Olanzapine for schizophrenia
ID - 455091
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/455091/all/__________Olanzapine_for_schizophrenia______
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -